Solid Biosciences files $200M common stock prospectus
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Solid Biosciences Inc. filed a prospectus supplement on August 6, 2026 under its universal shelf registration statement on Form S-3 (File No. 333-287325), covering the offer and sale of up to $200.0 million of common stock pursuant to an Amended and Restated Sales Agreement with Jefferies LLC.
This new supplement follows a prior prospectus supplement under a different Form S-3 that permitted up to $85.0 million of common stock sales; as of the new filing, the company has issued and sold shares for aggregate gross proceeds of approximately $85.0 million under that earlier capacity and will no longer use it for additional sales. A legal opinion from Wilmer Cutler Pickering Hale and Dorr LLP regarding the shares is filed as Exhibit 5.1, and offerings will be made only by means of the new prospectus supplement and base prospectus.
Filing Explained
The August 6 8-K reports a prospectus supplement establishing up to
8-K Event Classification
Key Figures
Key Terms
universal shelf registration statement regulatory
prospectus supplement regulatory
Form S-3 regulatory
base prospectus regulatory
Registration Statement regulatory
emerging growth company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Solid Biosciences (SLDB) report on August 6, 2026?
How large is Solid Biosciences’ new common stock capacity under the latest supplement?
What happened to Solid Biosciences’ prior $85.0 million prospectus supplement?
Which registration statement now covers the new Solid Biosciences (SLDB) offering?
Who is Solid Biosciences’ sales agent under the common stock Sales Agreement?
AI-generated analysis. How Rhea-AI works. Not financial advice.